| Title: |
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial |
| Authors: |
Hodi, F Stephen, Chesney, Jason, Pavlick, Anna C, Robert, Caroline, Grossmann, Kenneth F, McDermott, David F, Linette, Gerald P, Meyer, Nicolas, Giguere, Jeffrey K, Agarwala, Sanjiv S, Shaheen, Montaser, Ernstoff, Marc S, Minor, David R, Salama, April K, Taylor, Matthew H, Ott, Patrick A, Horak, Christine, Gagnier, Paul, Jiang, Joel, Wolchok, Jedd D, Postow, Michael A |
| Source: |
In The Lancet Oncology November 2016 17(11):1558-1568 |
| Database: |
ScienceDirect |
